Human medicines
Prezista
The marketing authorization holder informed its supplied customers in a letter dated 07.09.2011 that due to individual reports of an unpleasant, moldy…
Cardiolite/Neurolite
The distribution company has informed its supplied customers by letter dated August 29, 2011, that the batches indicated above may be contaminated…
Calcium "Fresenius" - Ampullen
The marketing authorization holder has informed its supplied customers by letter dated 23.08.2011 that a replacement will be carried out due to…
Enapril
The marketing authorization holder informed its supplied customers in a letter dated August 12, 2011, that individual tablets may break when they are…
Saroten Retard
The marketing authorization holder informed its supplied customers in a letter dated August 9, 2011, that the release of the active ingredient may be…
Lasix
The marketing authorization holder informed its supplied customers in a letter dated July 7, 2011, that another batch that had exceeded the 18-month…
Marcoumar
In a letter dated July 13, 2011, the marketing authorization holder informed its supplied customers that, in addition to the tablets, glass splinters…
Irinoliquid
In a letter dated July 7, 2011, the marketing authorization holder informed its customers that stability tests had revealed that the active ingredient…
Xylanaest 1 % with epinephrine
The marketing authorization holder informed its supplied customers in a letter dated July 5, 2011, that due to a calculation error an incorrect…
Rocaltrol
The medicinal product imported from Switzerland is being recalled as a precautionary measure, as stability tests have shown that the specified active…
